Clinical Trial Update: CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update reporting the completion of a study evaluating CIFN and interferon gamma-1b, with or without ribavirin, for chronic hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CIFN (Interferon alfacon-1)
• IFN-γ-1b (Interferon gamma-1b)
• Ribavirin (ribavirin)

Snippet

Sponsor: InterMune | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED